Scott M. Rocklage co-founded and started working with 5AM Ventures in 2003, and later in 2004, he became the Managing Partner. Dr. Rocklage has vast healthcare management experience for over three decades with strategic leadership responsibilities which led to approval of three U.S New Drug Applications pipelines by FDA namely Omniscan, Teslascan and Cubicin.
Dr. Rocklage has worked with many companies in different positions. She was the CEO of Cubist Pharmaceuticals and Nycomed Salutar and has also held R&D positions at Salutary and Catalytic. Besides that, he served as a chairman and a board chairman of Relypsa and Novira.
He is currently serving as board chairman of Rennovia, Kinestral, and Cidara as well as on boards of Epirus and Pulmatrix. He was formerly working as Executive Chairman of Miikana that was acquired by EntreMed.
He holds excellent education history. He received B.S in Chemistry from the University of California Berkeley. Scott obtained a Ph.D. in Chemistry from MIT where he conducted research in the laboratory of Richard R. Schrock and got a Nobel Prize in Chemistry in 2005. He has more than 100 peer-reviewed publications and an inventor or co-inventor of over 30 U.S patents.
He works with entrepreneurs may it be scientists, business executives and physicians to assist them to shape their ideas to help in the field of medicine. One trend that excites him is the explosive growth in the ability to target genotypes or specific mutations in the treatment of cancer. His business is a life science-based venture capital firm. The name 5 AM Ventures came about because his company specializes in the early stages of cancer treatment.
What makes him more productive as an entrepreneur is that he has excellent organizational skills with regards to time management, calendaring and prioritization (https://www.linkedin.com/in/scott-rocklage-66aa7a12a). Scott recommends if need be to understand the basis of business this book should be in your custody “Good to Great.” Dr. Scott is based in the Boston, and he believes that transforming ideas into reality requires self-determination and drive. He urges that staying close to the business enable you to learn the trends and how to improve the performances of your business.